Full Length Research Paper
References
|
Donnan GA, Fisher M, Macleod MM, Davis SM (2008). Stroke. Lancet 371:1612-1623. |
|
|
Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, Wang L, Jiang Y, Li Y, Wang Y (2017). Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation 135:759-771. |
|
|
Saver JL (2006). Time is brain--quantified. Stroke 37:263-266. |
|
|
Hua LXZ, Relebagen H, Bai L, Sun L, Ma C (2014). Effect of Erdun Wurile on Serum Components of Ischemic Stroke Patients. Chinese Journal of Experimental Traditional Medical Formulae 20:201-204. |
|
|
Tian L (2011). Observation of Clincal Therapeutic Effects of Erdun Wurile. Chinese Journal of Ethnomedicine and Ethnopharmacy 8:10-11. |
|
|
Zhan C, Yang J (2006). Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacological Research 53:303-309. |
|
|
Zhang TT, Lu CL, Jiang JG (2016) Neuroprotective and Anti-Inflammatory Effects of Diphenylheptanes from the Fruits of Amomum tsaoko, a Chinese Spice. Plant Foods and Human Nutrition 71:450-453. |
|
|
Han SY, Hong ZY, Xie YH, Zhao Y, Xu X (2017) Therapeutic effect of Chinese herbal medicines for post stroke recovery: A traditional and network meta-analysis. Medicine (Baltimore) 96:e8830. |
|
|
Gaowa S, Bao N, Da M, Qiburi Q, Ganbold T, Chen L, Altangerel A, Temuqile T, Baigude H (2018). Traditional Mongolian medicine Eerdun Wurile improves stroke recovery through regulation of gene expression in rat brain. Journal of Ethnopharmacology 222:249-260. |
|
|
Qiburi Q, Ganbold T, Bao Q, Da M, Aoqier A, Temuqile T, Baigude H (2020). Bioactive components of ethnomedicine Eerdun Wurile regulate the transcription of pro-inflammatory cytokines in microglia. Journal Ethnopharmacology 246:112241. |
|
|
Rodrigo R, Fernandez-Gajardo R, Gutierrez R, Matamala JM, Carrasco R, Miranda-Merchak A, Feuerhake W (2013). Oxidative stress and pathophysiology of ischemic stroke: Novel therapeutic opportunities. Formerly Current Drug Targets-CNS and Neurological Disorders) 12(5):698-714. |
|
|
Hayyan M, Hashim MA, AlNashef IM (2016). Superoxide Ion: Generation and Chemical Implications. Chemical Reviews 116:3029-3085. |
|
|
Spranger M, Krempien S, Schwab S, Donneberg S, Hacke W (1997). Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Correlation with clinical course and infarct size. Stroke 28:2425-2428. |
|
|
Pascal JM (2018). The comings and goings of PARP-1 in response to DNA damage. DNA Repair (Amst) 71:177-182. |
|
|
Oltvai ZN, Milliman CL, Korsmeyer SJ (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619. |
|
|
Krajewski S, Krajewska M, Ellerby LM, Welsh K, Xie Z, Deveraux QL, Salvesen GS, Bredesen DE, Rosenthal RE, Fiskum G (1999). Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proceedings of the National Academic Science USA 96:5752-5757. |
|
|
Burstein DE, Blumberg PM, Greene LA (1982). Nerve growth factor-induced neuronal differentiation of PC12 pheochromocytoma cells: Lack of inhibition by a tumor promoter. Brain Research 247:115-119. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
